Genetic dysfunction of the serotonin receptor 5-HT2A in psychiatric disorders;Disfunción genética del receptor de serotonina 5-HT2A en los trastornos psiquiátricos

Actas Espanolas de Psiquiatria

Volumn 29, Issue 2, 2001, Pages 131-138

  Arranz, B ^a,c   Rosel, P ^b   Ramirez N ^a   San, L ^a  

^a Benito Menni   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c CASM   (Spain)

Author keywords

5 HT2A receptor; Alcoholism; Anxiety; Bipolar disorder; Depression; Eating disorder; Personality disorder; Schizophrenia; Serotonin

Indexed keywords

SEROTONIN 2A RECEPTOR; SEROTONIN RECEPTOR;

ALCOHOLISM; ARTICLE; EATING DISORDER; GENETICS; HUMAN; MENTAL DISEASE; MOOD DISORDER; OBSESSIVE COMPULSIVE DISORDER; PERSONALITY DISORDER; SCHIZOPHRENIA;

ALCOHOLISM; EATING DISORDERS; HUMANS; MENTAL DISORDERS; MOOD DISORDERS; OBSESSIVE-COMPULSIVE DISORDER; PERSONALITY DISORDERS; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; SCHIZOPHRENIA;

EID: 0035287871     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Kendler KS, Walters EE, Neale MC, Kessler RC, Heath AC, Eaves LJ. The structure of the genetic and environmental risk factors for six major psychiatric disorders in women: phobia, generalized anxiety disorder, panic disorder, bulimia, major depression and alcoholism. Arch Gen Psychiatry 1995;52:374-83.
2. Arranz B, San L, González JM. Marcadores serotoninérgicos de la dependencia de alcohol. Trastornos Adictivos 1999;1:173-82.
3. Maes M, Meltzer HY. The serotonin hypothesis of major depression. En: Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press; 1995. p. 933-44.
4. Baxter G, Kennett GA, Blaney F, Blackburn TP. 5-HT2 receptor subtypes: a family re-united? TIPS 1995;16: 105-10.
5. Li TK, McBride WJ. Pharmacogenetic models of alcoholism. Clin Neurosci 1995;3:182-8.
6. Pandey SC, Piano MR, Schwartz DW, Davis JM, Pandey GN. Effect of ethanol administration and with-drawal on serotonin receptor subtypes and receptor-mediated phosphoinositide hydrolysis in rat brain Alcohol Clin Exp Res 1992;16:1110-6.
7. Arranz B, Rosel P, Sarró S, Zaldivar E, Cano R, Navarro MA, San L. Platelet serotonergic binding sites in alcohol dependent patients. Alcohol Alcohol 1999; 34:726-32.
8. Simonsson P, Alling C. The 5-hydroxytryptamine stimulated formation of inositol phosphate is inhibited in platelets from alcoholics. Life Sci 1988;42:385-91.
9. Nakamura T, Matsushita S, Nishiguchi N, Kimura M, Yoshino A, Higuchi S. Association of a polymorphism of the 5-HT2A receptor gene promoter region with alcohol dependence. Mol Psychiatry 1999;4:85-8.
10. Yoshihara E, Nakamura K, Itoh M, Ameno K, Takeuchi Y, Ijiri I, Iwahashi K. The human serotonin receptor gene (HTR2) Mspl polymorphism in japanese schizophrenic and alcoholic patients. Neuropsychobiology 2000;41:124-6.
11. Cloninger CR, Bohman M, Sigvardsson S. Inheritance of alcohol abuse: Cross-fostering analysis of adopted men. Arch Gen Psychiatry 1981;38:861-868.
12. Bennett JP, Enna SJ, Bylund DB, Gillin JC, Wyatt RJ, Snyder SH. Neurotransmitter receptors in frontal cortex of schizophrenics. Arch Gen Psychiatry 1979; 36:927-34.
13. Arora RC, Meltzer HY. Serotonin 2 (5-HT2) receptor binding in frontal cortex of schizophrenic patients. J Neural Transm Gen Sect 1991;85:19-29.
14. Dean B, Hayes W, Hill C, Copolov D. Decreased serotonin2A receptors in Brodmann's area 9 from schizophrenic subjects. A pathological or pharmacological phenomenon? Mol Chem Neuropathol 1998; 34:133-45.
15. Dean B, Hussain T, Hayes W, Scarr E, Kitsoulis S, Hill C, Opeskin K, Copolov DL. Changes in serotonin 2A and GABA(A) receptors in schizophrenia: studies on the human dorsolateral prefrontal cortex. J Neurochem 1999;72:1593-9.
16. Mita T, Hanada S, Nishino N, Kuno T, Nakai H, Yamadori T, Mizoi Y, Tanaka C. Decreased serotonin 2 and increased dopamine D2 receptors in chronic schizophrenics. Biol Psychiatry 1986;21:1407-14.
17. Joyce JN, Shane A, Lexow N, Winokur A, Casanova MF, Kleinman JE. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenia. Neuropsychopharmacology 1993;8: 315-36.
18. Whitaker PM, Crow TJ, Ferrier IN. Tritiated LSD binding in frontal cortex schizophrenia. Arch Gen Psychiatry 1981;38:278-80.
19. Schachter M, Geaney DP, Grahame-Smith DG, Cowen PJ, Elliot JM. Increased platelet membrane [3H]-LSD binding in patients on chronic neuroleptic treatment. Br J Clin Pharmacol 1985;19:453-7.
20. Pandey SC. Platelet serotonin-2 receptors in schizophrenia: effects of illness and neuroleptic treatment. Psychiatry Res 1993;48:57-68.
21. Mackay AVP, Doble A, Bird DE. [3H] Spiperone binding in normal and schizophrenic post-mortem human brain. Life Sci 1978;23:527-32.
22. Owen F, Cross AJ, Crow TJ. Neurotransmitter receptors in brain in schizophrenia. Acta Psychiatr Scand 1981;63:20-8.
23. Reynolds GP, Rossor MN, Iversen LL. Preliminary studies of human cortical 5-HT2 receptors and their involvement in schizophrenia and neuroleptic drug action. J Neural Transm Suppl 1983;18:273-7.
24. Arranz B, Eriksson A, Mellerup E, Plenge P, Marcusson J. Brain 5-HT1A, 5-HT1D and 5-HT2 receptors in suicide victims. Biol Psychiatry 1994;35:457-63.
25. Peroutka SJ, Snyder SH. Relationship of neuroleptic drug effects at brain dopamine, alpha-adrenergic and histamine to clinical potency. Am J Psychiatry 1980; 137:1518-22.
26. Andreé TH, Mikuni M, Tong CY, Koenig JI, Meltzer HY. Differential effect of subchronic treatment with various neuroleptic agents on serotonin2 receptors in rat cerebral cortex. J Neurochem 1986;46:191-7.
27. Arora RC, Meltzer HY. Effect of clozapine treatment on serotonin-2 receptor binding in the blood platelets of schizophrenic patients. Neuropsychopharmacology 1994;10:109-14.
28. Gothert M, Propping P, Bonisch H, Bruss M, Nothen MM. Genetic variation in human 5-HT receptors: potential pathogenetic and pharmacological role. Ann NY Acad Sci 1998;861:26-30.
29. Serretti A, Cusin C, Lorenzi C, Lattuada E, Lilli R, Smeraldi E. Serotonin-2A receptor gene is not associated with symptomatology of schizophrenia. Am J Med Genet 2000;96:84-7.
30. Joober R, Benkelfat C, Brisebois K, Toulouse A, Turecki G, Lal S, Bloom D, Labelle A, Lalonde P, Fortin D, Alda M, Palmour R, Rouleau GA. T102C polymorphism in the 5-HT2A gene and schizophrenia: relation to phenotype and drug response variability. J Psychiatry Neurosci 1999;24:141-6.
31. Lin CH, Tsai SJ, Yu YW, Song HL, Tu PC, Sim CB, Hsu CP, Yang KH, Hong CJ. No evidence for association of serotonin-2A receptor variant (102T/C) with schizophrenic or clozapine response in a Chinese population. Neuroreport 1999;10:57-60.
32. Shinkai T, Ohmori O, Kojima H, Terao T, Suzuki T, Abe K. Negative association between T102C polymorphism of the 5-HT2A receptor gene and schizophrenia in Japan. Hum Hered 1998;48:212-5.
33. Williams J, McGuffin P, Nothen M, Owen MJ and the EMASS Collaborative Group. Meta-analysis of association between the 5-HT2A receptor T102C polymorphism and schizophrenia. Lancet 1997;349:1221.
34. Arranz MJ, Collier D, Sodhi M. Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet 1995;346:281-2.
35. Arranz MJ, Collier DA, Munro J. Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine. Neurosci Lett 1996;217: 177-8.
36. Hernandez I, Sokolov BP. Abnormalities in 5-HT2A receptor mRNA expression in frontal cortex of chronic elderly schizophrenics with varying history of neuroleptic treatment. J Neurosci Res 2000;59:218-25.
37. Ohara K, Nagai M, Tani K, Tsukamoto T, Ohara K. Schizophrenic and the serotonin2A receptor promoter polymorphism. Psychiatry Res 1999;85:221-4.
38. Kouzmenko AP, Scaffidi A, Pereira AM, Hayes WL, Copolov DL, Dean B. No correlation between a(1438)G polymorphism in 5-HT2A receptor gene promoter and the density of frontal cortical 5-HT2A receptors in schizophrenia. Hum Hered 1999;49:103-5.
39. Birkett JT, Arranz MJ, Munro J, Osburn S, Kerwin RW, Collier DA. Association analysis of the 5-HT2A gene in depression, psychosis and antipsychotic response. Neuroreport 2000;9:2017-20.
40. Arranz B, San L, Rosel P, Callado LF, Meana JJ. La neurotransmisión monoaminérgica en el suicidio. I. El sistema serotoninérgico. Psiquiatr Biol 1997;4:205-12.
41. Turecki G, Briere R, Dewar K, Antonetti, Lesage AD, Seguin M, et al. Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. Am J Psychiatry 1999;156:1456-8.
42. Zhang HY, Ishigaki T, Tani K, Chen K, Shih JC, Miyasato K, Ohara K. Serotonin2A receptor gene polymorphism in mood disorders. Biol Psychiatry 1997; 41:768-73.
43. Serretti A, Lilli R, Lorenzi C, Smeraldi E. No association between serotonin-2A receptor gene polymorphism and psychotic symptomatology of mood disorders. Psychiatry Res 1999;86:203-9.
44. Cook EH, Fletcher KE, Wainwright M, Marks N, Yan S-Y, Leventhal BL. Primary structure of the human platelet serotonin 5-HT2A receptor: Identity with frontal cortex serotonin 5-Ht2A receptor. J Neurochem 1994;63:465-9.
45. Du L, Bakish D, Lapierre YD, Ravindran AV, Hrdina PD. Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder. Am J Med Genet 2000;96:56-60.
46. Sher L, Goldman D, Ozaki N, Rosenthal NE. The role of genetic factors in the etiology of seasonal affective disorder and seasonality. J Affect Disord 1999;53: 203-10.
47. Ohara K, Nagai M, Tsukamoto T, Tani K, Suzuki Y, Ohara K. 5-HT2A receptor gene promoter polymorphism 1438G/A and mood disorders. Neuroreport 1998;9:1139-41.
48. Gutiérrez B, Bertranpetit J, Collier D, Arranz MJ, Valles V, Guillamat R, Van Os J, Fañanas L. Genetic variation of the 5-HT2A receptor gene and bipolar affective disorder. Hum Genet 1997;100:582-4.
49. Mahieu B, Souery D, Lipp O, Mendelbaum K, Verheyen G, De Maertelaer V, et al. No association between bipolar affective disorder and a serotonin receptor (5-HT2A) polymorphism. Psychiatry Res 1997; 70:65-9.
50. Nicolini H, Cruz C, Camarena B, Orozco B, Kennedy JL, King N, et al. DRD2, DRD3 and 5-HT2A receptor genes polymorphisms in obsessive-compulsive disorder. Mol Psychiatry 1996;1:6461-5.
51. Frisch A, Michaelovsky FA, Rockah R, Amir I, Hermesh H, Laor N, et al. Association between obsessive-compulsive disorder and polimorphisms of genes encoding components of the serotonergic and dopaminergic pathways. Eur Neuropsychopharmacol 2000;10:205-9.
52. Hinney A, Ziegler A, Nothen MM, Remschmidt H, Hebebrand J. 5-HT2A receptor gene polymorphisms, anorexia nervosa and obesity. Lancet 1997;350:1324-5.
53. Spigset O, Andersen T, Hagg S, Mjondal T. Enhanced platelet serotonin 5-HT2A receptor binding in anorexia nervosa and bulimia nervosa. Eur Neuropsychopharmacol 1999;9:469-73.
54. Nacmias B, Ricca V, Tedde A, Mezzani B, Rotella CM, Sorbi S. 5-HT2A receptor gene polymorphism in anorexia nervosa and bulimia nervosa. Neurosci Lett 1999;277:134-6.
55. Peirson AR, Heuchert JW, Thomala L, Berk M, Plein H, Cloninger CR. Relationship between serotonin and the temperament and character inventory. Psychiatry Res 1999;89:29-37.
56. Coccaro EF, Kavoussi RJ, Sheline YI, Berman ME, Csernansky JG. Impulsive aggression in personality disorder correlates with platelet 5-HT2A receptor binding. Neuropsychopharmacology 1997;16:211-6.
57. Stein MB, Chartier MJ, Kozak MV, King N, Kennedy JL. Genetic linkage to the serotonin transporter protein and 5-HT2A receptor genes excluded in generalized social phobia. Psychiatry Res 1998;81:283-91.